AI assistant
JUPITER NEUROSCIENCES, INC. — Director's Dealing 2024
Nov 9, 2024
34460_dirs_2024-11-08_19c8ad3c-0b49-4fcb-a923-085550996ead.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: JUPITER NEUROSCIENCES, INC. (JUNS)
CIK: 0001679628
Period of Report: 2024-11-08
Reporting Person: Weis Holger (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock option (right to buy) | $1.33 | 2032-07-24 | Common Stock (67500) | Direct | |
| Stock option (right to buy) | $1.33 | 2033-09-28 | Common Stock (104625) | Direct | |
| Stock option (right to buy) | $1.33 | 2033-12-17 | Common Stock (8730) | Direct | |
| Restricted stock unit | $0 | 2033-12-17 | Common Stock (85800) | Direct | |
| Convertible notes | $2.80 | 2024-12-31 | Common Stock (8928) | Direct |
Footnotes
F1: Fully vested stock options which were granted on July 25, 2022 under the Company's 2021 Equity Incentive Plan.
F2: Fully vested stock options which were granted on September 29, 2023 pursuant to the approval of the board of directors of the issuer as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person.
F3: Fully vested stock options which were granted on December 18, 2023 pursuant to the approval of the board of directors of the issuer as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person.
F4: Restricted stock units which were granted on December 18, 2023 under the Company's 2023 Equity Incentive Plan as partial consideration for forgiveness of earned compensation owed by the issuer to the Reporting Person. The restricted stock units vest at 100% 180 days after the first day of trading of an IPO.
F5: Convertible note issued on August 9, 2021 with a principal balance of $25,000 with a conversion price of $2.80 per share.